Shenyang Xingqi Pharmaceutical Co.,Ltd (300573.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap11.9B
Enterprise Value11.61B
P/E Ratio14.79
PEG Ratio-0.75
Price/Sales Ratio4.43
Price/Book Ratio5.61
Enterprise/Revenue4.27
Enterprise/EBITDA12.19

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin0.29
Operating Margin0.34
AD

Management Effectiveness

Return On Assets0.27
Return On Equity0.37

Income Statement

Revenue2.47B
Revenue/Share7.85
Gross Profit2.01B
EBITDA917.4M
Net Income695.86M
Diluted EPS2.83

Balance Sheet

Total Cash537.82M
Total Cash/Share1.51
Total Debt98.31M
Total Debt/Equity0.04
Current Ratio1.89
Book Value Per Share6.25

Price History

52-Week Change-31.81
52-Week High58.92
52-Week Low32.7
Moving Average 50 Days35.54
Moving Average 200 Days41.8

Statistics

Average Volume5.25M
Shares Outstanding354.92M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1.3
Trailing Annual Dividend Yield3.71
Payout Ratio0.44
Last Split Factor29:20
Last Split DateMay 22, 2026
AD